
Senzime AB
SEZI · ST · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. The company offers TetraGraph, quantitative train of-four (TOF) monitoring refined by real-world patient data; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue's opposition to carrying an alternating electrical current. It also provides additional products, including CliniSenz Analyzer and OnZurf Probe. The company has a strategic connectivity and licensing agreement with Masimo that grants Senzime the rights to use some of Masimo's intellectual property; license agreement with Fukuda Denshi Co. Ltd. to license TetraGraph technology; and license agreement with CoreSpiron (Henan) Co Ltd. to manufacture and sell ExSpiron system. Senzime AB (publ) was incorporated in 1999 and is headquartered in Uppsala, Sweden.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Philip Siberg
- Employees59
- HeadquartersVerkstadsgatan 8, Uppsala, Sweden, 753 23, Sweden
- Websitehttps://www.senzime.com
Leadership
- Mr. Philip SibergChief Executive Officer · b. 1973
- Mr. Slavoljub GrujicicChief Financial Officer · b. 1970
- Ms. Johanna TulkkiExecutive VP & COO · b. 1970
- Mr. Anders JacobsonChief Scientific Officer · b. 1967
- Ms. Paula TreutigerHead of Communication & Investor Relations · b. 1967
- Mr. Michael NobleChief Marketing Officer · b. 1988
- Ms. Catrin MolundExecutive Vice President of Business Development · b. 1970
- Ms. Johanna FarisHead of Q/RA/S · b. 1975
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Stock Splits
- Feb 16, 2023948:935
- Mar 9, 2017585:574
- May 26, 201628:27
- Nov 27, 201432:29
- May 20, 2013520:471
- Aug 22, 2012515:502
- Feb 2, 201145:43
- Jan 5, 2010975:943